INHIBIKASE THERAPEUTICS

Company Information

Company Name
INHIBIKASE THERAPEUTICS
Address
3350 Riverwood Pkwy
Atlanta, GA, 30339-6451
Phone
n/a
URL
http://inhibikase.com
DUNS
828325899
Number of Employees
2

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$565,846.00
2
Chart code to be here

Award List

  1. PML antiviral for AIDS

    Amount: $265,846.00

    DESCRIPTION (provided by applicant): Inhibikase Therapeutics is an early stage biopharmaceutical company developing a novel strategy for treating infectious disease that occurs in AIDS patients. The ...

    SBIR Phase I 2009 Department of Health and Human Services
  2. System for multidimensional analysis of growth and migration of neurons and neuro

    Amount: $300,000.00

    DESCRIPTION (provided by applicant): Inhibikase Therapeutics is a clinical stage, biopharmaceutical company that has developed a host- targeted mechanism of action to treat AIDS-related and drug-induc ...

    SBIR Phase I 2013 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government